Explore how LC-MS and CE-MS technologies are transforming prostate cancer diagnosis through advanced biomarker analysis and metabolic fingerprinting.
Exploring how metabolomics delivers real-time snapshots of cellular physiology and revolutionizes precision medicine through molecular biomarkers.